Editorial - Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: Results from CaPSURE
BERKELEY, CA (UroToday.com) - In the online edition of Cancer, a group of investigators use the CaPSURE dataset to assess predictors of clinical metastasis in prostate cancer (CaP) patients on androgen-deprivation therapy (ADT).
 | Written by Christopher P. Evans, MD, a Contributing Editor with UroToday. |
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
